Cryoport Inc (CYRX) Stock Price, Quote & News

Company Profile

Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells offers cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry...

Industry: Integrated Freight & Logistics

Sector: Industrials

Phone: 949 470 2300

Website: www.cryoportinc.com

Address:

112 Westwood Place, Suite 350, Brentwood, United States

1DayAtAtime63 Mar. 14 at 1:27 PM

$CYRX At the Leerink Partners Global Healthcare Conference in Florida this past week Leerink put out a flash note on Cryoport and one of the many positive comments were"Importantly, the FY26 revenue guide does not assume contributions from new approvals, which require time for reimbursement, treatment center setup, and patient ramp."

0 · Reply

OfficialStocktwitsUser Mar. 4 at 11:37 AM

$CYRX RSI: 45.64, MACD: -0.3397 Vol: 0.32, MA20: 8.56, MA50: 9.50 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

erevnon Mar. 4 at 11:06 AM

Needham maintains CryoPort $CYRX at Buy and raises the price target from $12 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

anachartanalyst Mar. 4 at 10:01 AM

$CYRX https://anachart.com/wp-content/uploads/ana_temp/1772618477_soc-img.jpg

0 · Reply

StocktwitsEarnings Mar. 3 at 10:44 PM

$CYRX Q4 '25 Earnings Results & Recap Cryoport provides full-year 2026 revenue guidance in the range of $190M to $194M, reflecting an anticipated 8%-10% year-over-year growth for the company.

0 · Reply

DueDilly102 Mar. 3 at 10:11 PM

$CYRX revs growing...slowly but growing. Net income remaines elusive but close. Bought back 1.3million shares ave 7.45, which is a good purchase price. 69million remaining in buyback. Hopefully market likes it and we float up a bit...

0 · Reply

mikesterz7 Mar. 3 at 9:21 PM

$CYRX 🚨 🚨 🚨 FY 2025 revenue increased to $176.2 million, exceeding the high end of previous guidance Life Sciences Services revenue grew 18% year-over-year in FY 2025, including a 22% rise in BioStorage/BioServices revenue Commercial cell and gene therapy revenue increased 29% year-over-year to $33.4 million in FY 2025 Supported a record 760 global clinical trials and 20 commercially approved therapies as of December 31, 2025 Full-year 2026 revenue guidance of $190 million to $194 million (8%-10% growth y-o-y)

0 · Reply

StockNews_Live Mar. 3 at 9:07 PM

$CYRX Cryoport, Inc. announced financial results for its fourth quarter (Q4) and year ended (FY) December 31, 2025. The company reported full-year revenue of $176.2 million, exceeding the high end of previo…

0 · Reply

R33dh Mar. 3 at 7:53 PM

$CYRX let’s see how Shelton wants to bend us over this ER 😂

0 · Reply

DueDilly102 Feb. 12 at 6:02 PM

$CYRX Shelton, you are starting to act a bit too comfy in your position.

0 · Reply

Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript

Mar 3, 2026, 4:05 PM EST - 14 days ago

Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 17, 2026, 8:00 AM EST - 4 weeks ago

Cryoport to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Feb 11, 2026, 8:30 AM EST - 4 weeks ago

Cryoport's MVE Biological Solutions Introduces New Fusion® 800 Series

Dec 2, 2025, 9:14 AM EST - 3 months ago

Cryoport: Picks And Shovels For The Gene Therapy Boom

Nov 6, 2025, 12:30 PM EST - 4 months ago

Cryoport Systems Wins 2025 BioTech Breakthrough Award For “BioServices Innovation of the Year”

Nov 4, 2025, 11:56 PM EST - 4 months ago

Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:21 PM EST - 4 months ago

Cryoport Reports Strong Q3 Results, Raises FY25 Outlook

Nov 4, 2025, 4:05 PM EST - 4 months ago

Cryoport Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 8:30 AM EDT - 4 months ago

Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain

Oct 21, 2025, 8:00 AM EDT - 5 months ago

Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025

Oct 7, 2025, 8:30 AM EDT - 5 months ago

MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars

Oct 1, 2025, 8:30 AM EDT - 5 months ago

Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France

Aug 5, 2025, 8:05 PM EDT - 7 months ago

Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:19 PM EDT - 8 months ago

Cryoport Reports Second Quarter 2025 Financial Results

Jul 22, 2025, 8:00 AM EDT - 8 months ago

Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025

Jul 8, 2025, 8:00 AM EDT - 9 months ago

Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers

Jun 12, 2025, 8:00 AM EDT - 9 months ago

Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group

May 7, 2025, 7:15 PM EDT - 11 months ago

Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 11 months ago

Cryoport Reports First Quarter 2025 Financial Results

Apr 24, 2025, 8:30 AM EDT - 11 months ago

Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025

Mar 31, 2025, 3:11 PM EDT - 1 year ago

Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript)

Mar 31, 2025, 9:06 AM EDT - 1 year ago

DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"

Mar 31, 2025, 8:09 AM EDT - 1 year ago

Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET

Mar 12, 2025, 8:30 AM EDT - 1 year ago

Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories

Mar 4, 2025, 8:41 PM EST - 1 year ago

Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 4:10 PM EST - 1 year ago

Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 18, 2025, 8:30 AM EST - 1 year ago

Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Jan 21, 2025, 8:30 AM EST - 1 year ago

Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies

Jan 14, 2025, 8:30 AM EST - 1 year ago

Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Jan 6, 2025, 8:30 AM EST - 1 year ago

Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")

Nov 24, 2024, 11:51 PM EST - 1 year ago

Cryoport Remains A Disappointing Prospect

Nov 12, 2024, 8:30 AM EST - 1 year ago

Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe

Nov 9, 2024, 4:54 AM EST - 1 year ago

Cryoport, Inc. (CYRX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 1 year ago

Cryoport Reports Third Quarter 2024 Financial Results

Oct 29, 2024, 8:30 AM EDT - 1 year ago

Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services

Oct 21, 2024, 8:30 AM EDT - 1 year ago

TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics

Oct 15, 2024, 8:30 AM EDT - 1 year ago

VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies

Oct 7, 2024, 8:30 AM EDT - 1 year ago

Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus

Sep 25, 2024, 8:30 AM EDT - 1 year ago

SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices

Aug 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Inquiring Into Possible Securities Fraud By Cryoport Inc And Shareholders Are Encouraged To Reach Out

Aug 17, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Is Investigating Cryoport Inc And Asks Investors To Reach Out

Aug 16, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Cryoport Inc And Asks Shareholders To Reach Out

Aug 15, 2024, 7:00 PM EDT - 1 year ago

The Schall Law Firm Opens Investigation Into Cryoport Inc And Encourages Shareholders To Reach Out

Aug 14, 2024, 10:15 PM EDT - 1 year ago

The Schall Law Firm Initiates Investigation Into Claims Against Cryoport Inc And Urges Shareholders To Reach Out

1DayAtAtime63 Mar. 14 at 1:27 PM

0 · Reply

OfficialStocktwitsUser Mar. 4 at 11:37 AM

0 · Reply

erevnon Mar. 4 at 11:06 AM

Needham maintains CryoPort $CYRX at Buy and raises the price target from $12 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

anachartanalyst Mar. 4 at 10:01 AM

$CYRX https://anachart.com/wp-content/uploads/ana_temp/1772618477_soc-img.jpg

0 · Reply

StocktwitsEarnings Mar. 3 at 10:44 PM

$CYRX Q4 '25 Earnings Results & Recap Cryoport provides full-year 2026 revenue guidance in the range of $190M to $194M, reflecting an anticipated 8%-10% year-over-year growth for the company.

0 · Reply

DueDilly102 Mar. 3 at 10:11 PM

0 · Reply

mikesterz7 Mar. 3 at 9:21 PM

0 · Reply

StockNews_Live Mar. 3 at 9:07 PM

0 · Reply

R33dh Mar. 3 at 7:53 PM

$CYRX let’s see how Shelton wants to bend us over this ER 😂

0 · Reply

DueDilly102 Feb. 12 at 6:02 PM

$CYRX Shelton, you are starting to act a bit too comfy in your position.

0 · Reply

DueDilly102 Jan. 22 at 10:05 PM

$CYRX Amazing the xbi up 2.5% today and we are down on the day.

0 · Reply

OfficialStocktwitsUser Jan. 16 at 9:49 PM

$CYRX RSI: 76.86, MACD: 0.4134 Vol: 0.60, MA20: 10.11, MA50: 9.52 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

1DayAtAtime63 Jan. 16 at 8:22 PM

$CYRX FYI.. Anktiva sales are up 700% yoy. CYRX ships this treatment for ImmunityBio. This is just one of the many companys that CYRX services that is accelerating at a rapid pace.

0 · Reply

DonWestTrading Jan. 16 at 1:34 AM

$CYRX cryptocurrency port WOW!

0 · Reply

R33dh Jan. 2 at 8:59 PM

$CYRX #FIREJERRY

0 · Reply

BillionerOfKing Dec. 30 at 6:42 AM

$CYRX Current Stock Price: $9.53 Contracts to trade: $10 CYRX Jan 16 2026 Call Entry: $0.33 Exit: $0.64 ROI: 93% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

InsightInsider Dec. 26 at 7:36 AM

$CYRX This name increasingly trades on execution rhythm rather than speculation about possibilities. Governance alignment matters more at this stage. Sustained momentum may broaden institutional interest. Credibility grows when performance becomes repeatable.

1 · Reply

HongKongHedge Dec. 24 at 12:45 PM

$CYRX Market attention is shifting toward whether timelines compress uncertainty rather than extend speculation. Sustained traction would support a meaningful re-rating.

0 · Reply

Doozio Dec. 23 at 10:12 PM

$CYRX it’s had its dip and Roger is ready to rock outta da tightness on the DLO ENTA 🐒🍌🧠⏰♾️

0 · Reply

DueDilly102 Dec. 17 at 2:25 PM

$CYRX Wonder if we'll ever hit 15 again. Feels like we are an 'old' stock that has zero allure any longer, no hype, slow growth, no profits. Nothing exciting anymore. Shelton has been talking about profits for many years but cant produce. I wonder how much longer a guy waits...

0 · Reply

SuperGreenToday Dec. 10 at 7:53 PM

$CYRX Share Price: $9.94 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.61 – $1.96 Potential Upside: 79% ROI Time to Expiration: 155 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

agamemnus Nov. 25 at 9:40 PM

$CYRX they suppressed the stock price for weeks just so they could kill a few thousand dollars of calls. Gross.

0 · Reply

Market Cap	389.87M
Revenue (ttm)	176.18M
Net Income (ttm)	78.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	44.44%
Debt to Equity Ratio	0.00

Volume	401,700
Avg Vol	384,692
Day's Range	N/A - N/A
Shares Out	49.86M
Stochastic %K	21%
Beta	1.69
Analysts	Strong Sell
Price Target	$13.33